The associations of anthropometric, behavioural and sociodemographic factors with circulating concentrations of IGF-I, IGF-II, IGFBP-1, IGFBP-2 and IGFBP-3 in a pooled analysis of 16,024 men from 22 studies
Eleanor L Watts,Aurora Perez-Cornago,Paul N Appleby,Demetrius Albanes,Eva Ardanaz,Amanda Black,H Bas Bueno-de-Mesquita,June M Chan,Chu Chen,S A Paul Chubb,Michael B Cook,Mélanie Deschasaux,Jenny L Donovan,Dallas R English,Leon Flicker,Neal D Freedman,Pilar Galan,Graham G Giles,Edward L Giovannucci,Marc J Gunter,Laurel A Habel,Christel Häggström,Christopher Haiman,Freddie C Hamdy,Serge Hercberg,Jeff M Holly,Jiaqi Huang,Wen-Yi Huang,Mattias Johansson,Rudolf Kaaks,Tatsuhiko Kubo,J Athene Lane,Tracy M Layne,Loic Le Marchand,Richard M Martin,E Jeffrey Metter,Kazuya Mikami,Roger L Milne,Howard A Morris,Lorelei A Mucci,David E Neal,Marian L Neuhouser,Steven E Oliver,Kim Overvad,Kotaro Ozasa,Valeria Pala,Claire H Pernar,Michael Pollak,Mari-Anne Rowlands,Catherine A Schaefer,Jeannette M Schenk,Pär Stattin,Akiko Tamakoshi,Elin Thysell,Mathilde Touvier,Antonia Trichopoulou,Konstantinos K Tsilidis,Stephen K Van Den Eeden,Stephanie J Weinstein,Lynne Wilkens,Bu B Yeap,Timothy J Key,Naomi E Allen,Ruth C Travis
DOI: https://doi.org/10.1002/ijc.32276
2019-12-15
Abstract:Insulin-like growth factors (IGFs) and insulin-like growth factor binding proteins (IGFBPs) have been implicated in the aetiology of several cancers. To better understand whether anthropometric, behavioural and sociodemographic factors may play a role in cancer risk via IGF signalling, we examined the cross-sectional associations of these exposures with circulating concentrations of IGFs (IGF-I and IGF-II) and IGFBPs (IGFBP-1, IGFBP-2 and IGFBP-3). The Endogenous Hormones, Nutritional Biomarkers and Prostate Cancer Collaborative Group dataset includes individual participant data from 16,024 male controls (i.e. without prostate cancer) aged 22-89 years from 22 prospective studies. Geometric means of protein concentrations were estimated using analysis of variance, adjusted for relevant covariates. Older age was associated with higher concentrations of IGFBP-1 and IGFBP-2 and lower concentrations of IGF-I, IGF-II and IGFBP-3. Higher body mass index was associated with lower concentrations of IGFBP-1 and IGFBP-2. Taller height was associated with higher concentrations of IGF-I and IGFBP-3 and lower concentrations of IGFBP-1. Smokers had higher concentrations of IGFBP-1 and IGFBP-2 and lower concentrations of IGFBP-3 than nonsmokers. Higher alcohol consumption was associated with higher concentrations of IGF-II and lower concentrations of IGF-I and IGFBP-2. African Americans had lower concentrations of IGF-II, IGFBP-1, IGFBP-2 and IGFBP-3 and Hispanics had lower IGF-I, IGF-II and IGFBP-3 than non-Hispanic whites. These findings indicate that a range of anthropometric, behavioural and sociodemographic factors are associated with circulating concentrations of IGFs and IGFBPs in men, which will lead to a greater understanding of the mechanisms through which these factors influence cancer risk.